United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Healthcare Industry News Poly Medicure stock in focus as €18.3m PendraCare deal opens doors to Europe and U.S. cardiology markets Poly Medicure acquires Dutch firm PendraCare for €18.3M to expand its cardiology vertical globally. Analysts watch integration roadmap and earnings impact. byPallavi MadhirajuSeptember 3, 2025